IL6/JAK/STAT3 signalling was enhanced in M1-like MΦ of the CCI patient group, which was also activated in the mouse model in the resident-like MΦs, in TC1 tumours treated with the caerin peptide gel (Figure 3). This evidence concerns the gene IL6 and neoplasm.